搜尋
市場行情
自選股
新聞
分析
交易工具
選股工具
掃碼下載
一鍵診股 讓投資更聰明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登入
免費註冊
搜尋
免費註冊
市場行情
/
股票
/
醫藥與醫學研究
/
生物技術與醫療研究
/
inm
/
財務摘要
InMed Pharmaceuticals Inc
INM
添加自選
1.400
USD
+0.010
+0.72%
交易中 09/23, 09:34(美東)
4.63M
總市值
虧損
本益比TTM
InMed Pharmaceuticals Inc
1.400
+0.010
+0.72%
概覽
新聞分析
財務
股票評分
技術分析
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
財報
公司估值
風險評估
概覽
新聞分析
財務
股票評分
技術分析
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
財報
公司估值
風險評估
INM 財務數據
透過專為投資者打造的一站式數據看板,全面查看 InMed Pharmaceuticals Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。
關鍵財務比率
總市值
4.63M
股利TTM
0.00
本益比TTM
-0.66
每股盈餘TTM
-2.12
營業收入
--
淨利潤
-8.16M
淨資產收益率
-112.65%
總資產收益率
-85.12%
InMed Pharmaceuticals Inc 財報行事曆
最新發布
5月 6, 2026
每股收益 / 預測值
--
/
--
營業收入 / 預測值
--
/
--
財務報表摘要
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
財務指標
每股收益
-3.70%
-1.24
62.14%
-0.73
85.93%
-0.51
99.19%
-0.44
70.32%
-1.20
46.01%
-1.94
1.71%
-3.64
-254.97%
-54.11
-98.36%
-4.04
70.15%
-3.58
79.70%
-3.71
81.20%
-15.24
--
-2.04
--
-12.01
--
-18.27
--
-81.10
--
--
--
--
--
--
--
--
營業收入
--
--
--
--
-26.22%
820.19K
-11.43%
1.12M
1.69%
1.30M
7.59%
1.26M
-10.36%
1.11M
40.23%
1.26M
-44.48%
1.28M
13.41%
1.17M
163.99%
1.24M
181.14%
901.86K
348.96%
2.31M
233.97%
1.03M
77.22%
469.78K
--
320.79K
--
514.76K
--
309.58K
--
265.09K
--
--
淨利潤
-226.53%
-5.84M
-39.86%
-2.97M
21.23%
-2.03M
-2.92%
-1.73M
7.71%
-1.79M
-23.10%
-2.12M
-74.20%
-2.58M
33.86%
-1.68M
-472.61%
-1.94M
13.77%
-1.72M
29.65%
-1.48M
27.73%
-2.54M
95.70%
-338.39K
42.52%
-2.00M
50.94%
-2.10M
-18.12%
-3.51M
-141.50%
-7.87M
-12.06%
-3.48M
-90.87%
-4.28M
-85.83%
-2.97M
利潤率
--
--
--
--
-6.76%
-247.29%
-16.20%
-154.17%
9.24%
-137.07%
-14.42%
-168.12%
-94.34%
-231.63%
52.83%
-132.68%
-931.39%
-151.02%
23.97%
-146.93%
73.35%
-119.19%
74.29%
-281.29%
--
-14.64%
--
-193.24%
--
-447.25%
--
-1094.24%
--
--
--
--
--
--
--
--
毛利率
--
--
--
--
-56.45%
15.97%
2.82%
31.24%
25.26%
40.15%
-71.88%
5.63%
69.13%
36.67%
915.80%
30.38%
-51.16%
32.06%
45.91%
20.01%
24.05%
21.68%
97.79%
-3.72%
--
65.64%
--
13.72%
--
17.48%
--
-168.36%
--
--
--
--
--
--
--
--
利潤表
營業收入
--
--
--
--
-26.22%
820.19K
-11.43%
1.12M
1.69%
1.30M
7.59%
1.26M
-10.36%
1.11M
40.23%
1.26M
-44.48%
1.28M
13.41%
1.17M
163.99%
1.24M
181.14%
901.86K
348.96%
2.31M
233.97%
1.03M
77.22%
469.78K
--
320.79K
--
514.76K
--
309.58K
--
265.09K
--
--
營業利潤
-74.32%
-3.21M
-36.62%
-2.82M
3.88%
-2.12M
-0.54%
-1.76M
8.31%
-1.84M
-17.77%
-2.12M
-29.41%
-2.21M
33.16%
-1.75M
-289.14%
-2.01M
16.43%
-1.80M
23.69%
-1.70M
24.57%
-2.62M
83.06%
-516.26K
39.28%
-2.15M
45.67%
-2.23M
-20.28%
-3.48M
7.83%
-3.05M
-12.95%
-3.54M
-112.59%
-4.11M
-84.96%
-2.89M
淨利潤
-226.53%
-5.84M
-39.86%
-2.97M
21.23%
-2.03M
-2.92%
-1.73M
7.71%
-1.79M
-23.10%
-2.12M
-74.20%
-2.58M
33.86%
-1.68M
-472.61%
-1.94M
13.77%
-1.72M
29.65%
-1.48M
27.73%
-2.54M
95.70%
-338.39K
42.52%
-2.00M
50.94%
-2.10M
-18.12%
-3.51M
-141.50%
-7.87M
-12.06%
-3.48M
-90.87%
-4.28M
-85.83%
-2.97M
資產負債表
流動資產
-79.20%
2.68M
7.46%
6.89M
60.67%
8.79M
48.35%
10.80M
48.08%
12.87M
-36.31%
6.41M
-53.68%
5.47M
-12.24%
7.28M
-23.32%
8.69M
-15.02%
10.06M
-15.75%
11.81M
-28.14%
8.30M
18.07%
11.33M
35.39%
11.84M
12.10%
14.02M
-27.75%
11.54M
14.56%
9.60M
-19.73%
8.75M
22.01%
12.51M
--
15.98M
流動負債總額
6.27%
1.96M
20.25%
2.21M
-17.36%
1.48M
8.29%
1.55M
-6.70%
1.84M
20.29%
1.84M
6.57%
1.79M
7.22%
1.44M
-1.44%
1.97M
-32.64%
1.53M
-30.00%
1.68M
-59.19%
1.34M
-39.73%
2.00M
-44.72%
2.27M
-48.01%
2.40M
70.32%
3.28M
49.84%
3.32M
139.49%
4.11M
114.42%
4.62M
--
1.93M
總資產
-80.55%
3.03M
-1.57%
9.13M
31.63%
11.19M
27.67%
13.36M
31.78%
15.58M
-30.53%
9.28M
-44.27%
8.50M
-4.14%
10.47M
-16.19%
11.82M
-9.31%
13.36M
-9.84%
15.26M
-25.14%
10.92M
10.31%
14.11M
-4.88%
14.73M
-12.71%
16.92M
-15.83%
14.58M
30.74%
12.79M
25.44%
15.49M
65.00%
19.38M
--
17.33M
總負債
-8.88%
1.96M
-0.72%
2.24M
-30.88%
1.60M
-14.46%
1.77M
-18.00%
2.15M
0.19%
2.26M
-6.57%
2.32M
54.54%
2.07M
29.76%
2.62M
-3.77%
2.25M
-3.92%
2.48M
-62.55%
1.34M
-45.63%
2.02M
-49.07%
2.34M
-50.45%
2.58M
69.85%
3.58M
54.24%
3.71M
138.23%
4.60M
25.50%
5.22M
--
2.11M
總權益
-92.00%
1.08M
-1.85%
6.89M
55.09%
9.59M
38.06%
11.59M
45.93%
13.43M
-36.77%
7.02M
-51.60%
6.18M
-12.35%
8.40M
-23.85%
9.21M
-10.36%
11.10M
-10.90%
12.77M
-12.99%
9.58M
33.17%
12.09M
13.79%
12.39M
1.18%
14.34M
-27.68%
11.01M
23.07%
9.08M
4.53%
10.89M
86.64%
14.17M
--
15.22M
現金流量表
經營淨額
-77.39%
-3.15M
-82.14%
-3.02M
5.03%
-2.38M
12.00%
-1.61M
-72.81%
-1.78M
14.21%
-1.66M
-35.39%
-2.50M
15.98%
-1.83M
-56.42%
-1.03M
-16.76%
-1.93M
31.88%
-1.85M
3.61%
-2.17M
83.74%
-657.93K
69.03%
-1.66M
23.22%
-2.71M
15.01%
-2.26M
-101.75%
-4.05M
-15.99%
-5.35M
--
-3.53M
-93.49%
-2.65M
投資淨額
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
100.00%
0.00
100.00%
0.00
--
0.00
100.00%
0.00
100.00%
-2.00
98.14%
-9.29K
--
0.00
95.37%
-33.61K
-3508.16%
-128.20K
-263.39%
-500.00K
100.00%
0.00
-41955.48%
-725.46K
--
-3.55K
--
306.01K
--
-250.00K
融資淨額
-100.00%
-1.00
-92.07%
231.68K
-100.00%
0.00
-116.37%
-137.18K
4644531.25%
8.17M
--
2.92M
-92.73%
338.52K
--
838.24K
--
176.00
100.00%
0.00
-12.44%
4.65M
-100.00%
0.00
-100.00%
0.00
-117.31%
-63.70K
735.69%
5.32M
-50.12%
5.43M
6172.97%
5.05M
-100.72%
-29.31K
--
-836.14K
16936.86%
10.88M
常見問題
InMed Pharmaceuticals Inc的流動資產是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,流動資產為2.68M(同比變化-79.20)。
InMed Pharmaceuticals Inc的總資產是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,InMed Pharmaceuticals Inc的總資產為3.03M(同比變化-80.55)。
InMed Pharmaceuticals Inc的總負債是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,InMed Pharmaceuticals Inc的總責任為1.96M(同比變化-8.88)。
InMed Pharmaceuticals Inc的總權益是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,InMed Pharmaceuticals Inc的總權益為1.08M(同比變化-92.00)。
InMed Pharmaceuticals Inc的淨營業收入是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,InMed Pharmaceuticals Inc的淨營業收入為-9.90M(同比變化-24.97)。
InMed Pharmaceuticals Inc的淨融資是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,InMed Pharmaceuticals Inc的淨融資為94.50K(同比變化-99.23)。
InMed Pharmaceuticals Inc的每股收益(EPS)是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,每股收益(EPS)為-3.02(同比變化63.93)。
InMed Pharmaceuticals Inc的淨利潤是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,淨利潤為-12.56M(同比變化-53.89)。
InMed Pharmaceuticals Inc的股東權益回報率(ROE)是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,股東權益回報率(ROE)為-156.77(同比變化-117.43)。
InMed Pharmaceuticals Inc的資產回報率(ROA)是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,資產回報率(ROA)為-122.23(同比變化-105.17)。
InMed Pharmaceuticals Inc的營業利潤是多少?
根據InMed Pharmaceuticals Inc的FY2026財報,營業利潤為-9.90M(同比變化-24.97)。